RJA
XLV icon

Raymond James & Associates’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Raymond James & Associates’s Portfolio XLV Stock Details XLV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$631M Sell
4,093,965
-495,409
-11% -$75.1M 0.38% 45
2024
Q2 		$669M Sell
4,589,374
-1,093,532
-19% -$157M 0.44% 39
2024
Q1 		$840M Buy
5,682,906
+82,804
+1% +$11.9M 0.57% 28
2023
Q4 		$764M Buy
5,600,102
+378,702
+7% +$49.3M 0.57% 26
2023
Q3 		$672M Buy
5,221,400
+119,011
+2% +$15.8M 0.56% 28
2023
Q2 		$677M Buy
5,102,389
+403,847
+9% +$53.2M 0.56% 26
2023
Q1 		$608M Sell
4,698,542
-203,102
-4% -$26.5M 0.53% 31
2022
Q4 		$666M Buy
4,901,644
+105,540
+2% +$14M 0.61% 24
2022
Q3 		$581M Buy
4,796,104
+275,367
+6% +$35.5M 0.59% 23
2022
Q2 		$580M Buy
4,520,737
+863,876
+24% +$113M 0.57% 25
2022
Q1 		$501M Buy
3,656,861
+721,207
+25% +$95.5M 0.42% 40
2021
Q4 		$414M Buy
2,935,654
+361,933
+14% +$48.1M 0.33% 57
2021
Q3 		$328M Buy
2,573,721
+226,764
+10% +$30M 0.29% 61
2021
Q2 		$296M Buy
2,346,957
+322,980
+16% +$39.6M 0.27% 63
2021
Q1 		$236M Buy
2,023,977
+98,196
+5% +$11.3M 0.24% 76
2020
Q4 		$218M Sell
1,925,781
-87,651
-4% -$9.57M 0.24% 72
2020
Q3 		$212M Buy
2,013,432
+100,458
+5% +$10.6M 0.27% 66
2020
Q2 		$191M Buy
1,912,974
+241,548
+14% +$23.8M 0.26% 70
2020
Q1 		$148M Buy
1,671,426
+242,947
+17% +$23.6M 0.24% 76
2019
Q4 		$146M Buy
1,428,479
+169,254
+13% +$16.3M 0.18% 100
2019
Q3 		$113M Buy
1,259,225
+114,445
+10% +$10.4M 0.16% 120
2019
Q2 		$106M Sell
1,144,780
-16,065
-1% -$1.44M 0.15% 125
2019
Q1 		$107M Sell
1,160,845
-51,735
-4% -$4.66M 0.16% 120
2018
Q4 		$105M Buy
1,212,580
+202,108
+20% +$18.3M 0.18% 100
2018
Q3 		$96.1M Buy
1,010,472
+22,511
+2% +$2.03M 0.15% 128
2018
Q2 		$82.5M Buy
987,961
+3,212
+0.3% +$266K 0.14% 139
2018
Q1 		$80.2M Buy
984,749
+58,616
+6% +$4.99M 0.14% 139
2017
Q4 		$76.6M Buy
926,133
+39,081
+4% +$3.22M 0.14% 134
2017
Q3 		$72.5M Buy
887,052
+244,803
+38% +$19.7M 0.15% 136
2017
Q2 		$50.9M Buy
642,249
+83,100
+15% +$6.33M 0.11% 181
2017
Q1 		$41.6M Buy
559,149
+170,404
+44% +$12.4M 0.1% 211
2016
Q4 		$26.8M Buy
388,745
+40,402
+12% +$2.81M 0.07% 282
2016
Q3 		$25.1M Buy
348,343
+96,079
+38% +$7.07M 0.07% 280
2016
Q2 		$18.1M Buy
252,264
+70,063
+38% +$4.94M 0.06% 348
2016
Q1 		$12.3M Sell
182,201
-19,637
-10% -$1.32M 0.04% 446
2015
Q4 		$14.5M Buy
201,838
+16,549
+9% +$1.17M 0.05% 386
2015
Q3 		$12.3M Sell
185,289
-220,585
-54% -$16.1M 0.05% 411
2015
Q2 		$30.2M Buy
405,874
+80,699
+25% +$5.98M 0.12% 195
2015
Q1 		$23.6M Buy
325,175
+131,823
+68% +$9.4M 0.1% 212
2014
Q4 		$13.2M Buy
193,352
+98,843
+105% +$6.62M 0.06% 321
2014
Q3 		$6.04M Buy
94,509
+3,172
+3% +$199K 0.03% 543
2014
Q2 		$5.56M Buy
91,337
+9,184
+11% +$540K 0.03% 588
2014
Q1 		$4.8M Buy
82,153
+2,072
+3% +$119K 0.03% 594
2013
Q4 		$4.44M Sell
80,081
-10,343
-11% -$553K 0.03% 577
2013
Q3 		$4.58M Buy
90,424
+415
+0.5% +$20.9K 0.04% 508
2013
Q2 		$4.29M Buy
+90,009
New +$4.31M 0.04% 482

Other funds holding XLV

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
NAM
Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James & Associates's XLV Position: Q3 2024 in Review

Raymond James & Associates reduced its State Street Health Care Select Sector SPDR ETF (XLV) stake by 11% in Q3 2024, selling an estimated $75.1M and leaving 4,093,965 shares worth $631M. The position accounts for 0.38% of the portfolio, ranked #45.

Raymond James & Associates first reported a position in XLV in Q2 2013 and has held it in 46 quarters since. The position peaked at $840M in Q1 2024. 1,728 funds tracked by Wall St. Rank hold XLV as of Q3 2024.

  • Raymond James & Associates held 4,093,965 shares of State Street Health Care Select Sector SPDR ETF worth $631M as of Q3 2024.
  • Raymond James & Associates sold 495,409 State Street Health Care Select Sector SPDR ETF shares in Q3 2024, an estimated $75.1M.
  • State Street Health Care Select Sector SPDR ETF made up 0.38% of Raymond James & Associates's portfolio in Q3 2024, its #45 holding.
  • Raymond James & Associates first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's State Street Health Care Select Sector SPDR ETF position peaked at $840M in Q1 2024.
  • 1,728 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.